Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306168032> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4306168032 endingPage "1899" @default.
- W4306168032 startingPage "1896" @default.
- W4306168032 abstract "In 2021, the European and American Infectious Diseases Societies published new guidelines for the treatment of Clostridiodes difficile colitis. They have opted for a change in practice with fidaxomicin being recommended as the first line of treatment, and vancomycin as a second choice. Metronidazole remains recommended only in cases where other treatments are not available. These choices have not been endorsed by the Swiss Infectious Diseases Society, which still proposes metronidazole as first-line treatment. As a matter of fact, this inexpensive treatment still presents a satisfactory efficacy on the strains of Clostridoides difficile found in Switzerland in the context of patients without risk factors and with low probability of relapse.En 2021, les sociétés d’infectiologie européenne et américaine ont publié des guidelines relatives au traitement des colites à Clostridioides difficile. Elles ont opté pour un changement des pratiques avec la recommandation en première ligne de la fidaxomicine, la vancomycine devenant un deuxième choix. Le métronidazole est préconisé uniquement dans les cas où les autres traitements ne seraient pas disponibles. Ces choix n’ont pas été repris par la Société suisse d’infectiologie, qui propose toujours le métronidazole en première intention. En effet, ce traitement peu coûteux présente encore une efficacité satisfaisante sur les souches retrouvées en Suisse dans le cadre des colites à Clostridioides difficile sans facteurs de risque et à faible probabilité de rechute." @default.
- W4306168032 created "2022-10-14" @default.
- W4306168032 creator A5046617748 @default.
- W4306168032 creator A5084042644 @default.
- W4306168032 date "2022-01-01" @default.
- W4306168032 modified "2023-10-16" @default.
- W4306168032 title "Infection à [i]Clostridioides difficile [/i]: approches thérapeutiques diverses" @default.
- W4306168032 doi "https://doi.org/10.53738/revmed.2022.18.799.1896" @default.
- W4306168032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36226451" @default.
- W4306168032 hasPublicationYear "2022" @default.
- W4306168032 type Work @default.
- W4306168032 citedByCount "0" @default.
- W4306168032 crossrefType "journal-article" @default.
- W4306168032 hasAuthorship W4306168032A5046617748 @default.
- W4306168032 hasAuthorship W4306168032A5084042644 @default.
- W4306168032 hasConcept C126322002 @default.
- W4306168032 hasConcept C138885662 @default.
- W4306168032 hasConcept C151730666 @default.
- W4306168032 hasConcept C15708023 @default.
- W4306168032 hasConcept C2777396551 @default.
- W4306168032 hasConcept C2778980435 @default.
- W4306168032 hasConcept C2779343474 @default.
- W4306168032 hasConcept C2779489039 @default.
- W4306168032 hasConcept C2781342628 @default.
- W4306168032 hasConcept C2910067853 @default.
- W4306168032 hasConcept C29456083 @default.
- W4306168032 hasConcept C501593827 @default.
- W4306168032 hasConcept C523546767 @default.
- W4306168032 hasConcept C54355233 @default.
- W4306168032 hasConcept C71924100 @default.
- W4306168032 hasConcept C86803240 @default.
- W4306168032 hasConcept C89423630 @default.
- W4306168032 hasConceptScore W4306168032C126322002 @default.
- W4306168032 hasConceptScore W4306168032C138885662 @default.
- W4306168032 hasConceptScore W4306168032C151730666 @default.
- W4306168032 hasConceptScore W4306168032C15708023 @default.
- W4306168032 hasConceptScore W4306168032C2777396551 @default.
- W4306168032 hasConceptScore W4306168032C2778980435 @default.
- W4306168032 hasConceptScore W4306168032C2779343474 @default.
- W4306168032 hasConceptScore W4306168032C2779489039 @default.
- W4306168032 hasConceptScore W4306168032C2781342628 @default.
- W4306168032 hasConceptScore W4306168032C2910067853 @default.
- W4306168032 hasConceptScore W4306168032C29456083 @default.
- W4306168032 hasConceptScore W4306168032C501593827 @default.
- W4306168032 hasConceptScore W4306168032C523546767 @default.
- W4306168032 hasConceptScore W4306168032C54355233 @default.
- W4306168032 hasConceptScore W4306168032C71924100 @default.
- W4306168032 hasConceptScore W4306168032C86803240 @default.
- W4306168032 hasConceptScore W4306168032C89423630 @default.
- W4306168032 hasIssue "799" @default.
- W4306168032 hasLocation W43061680321 @default.
- W4306168032 hasLocation W43061680322 @default.
- W4306168032 hasOpenAccess W4306168032 @default.
- W4306168032 hasPrimaryLocation W43061680321 @default.
- W4306168032 hasRelatedWork W2951496795 @default.
- W4306168032 hasRelatedWork W3015201063 @default.
- W4306168032 hasRelatedWork W3108100673 @default.
- W4306168032 hasRelatedWork W3160363432 @default.
- W4306168032 hasRelatedWork W3165763903 @default.
- W4306168032 hasRelatedWork W3212830400 @default.
- W4306168032 hasRelatedWork W4283011691 @default.
- W4306168032 hasRelatedWork W4294225883 @default.
- W4306168032 hasRelatedWork W4313826038 @default.
- W4306168032 hasRelatedWork W4352986855 @default.
- W4306168032 hasVolume "18" @default.
- W4306168032 isParatext "false" @default.
- W4306168032 isRetracted "false" @default.
- W4306168032 workType "article" @default.